NCT03065257

Brief Summary

This is a retrospective and prospective multicenter registry to collect long-term data (1 year) on patients who have or will undergo Endoscopic resection such as EMR, ESD, EFTR, STER, etc. within the gastrointestinal tract for endoscopic treatment of early gastrointestinal neoplasms involving the resection of the superficial layers, mucosa and submucosa, of the tract wall. Subjects will be consented for medical chart review. The purpose of this retrospective and prospective registry is to assess long term data on efficacy, safety and clinical outcome of Endoscopic Resection within the gastrointestinal tract (1 year). The registry will evaluate efficacy, technical feasibility, clinical outcome, safety profile and overall clinical management through medical chart review. The procedures the investigators are evaluating are all clinically indicated and will not be prescribed to someone to participate in this registry study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 16, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 27, 2017

Completed
16 days until next milestone

Study Start

First participant enrolled

March 15, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2020

Completed
Last Updated

April 25, 2017

Status Verified

April 1, 2017

Enrollment Period

3 years

First QC Date

February 16, 2017

Last Update Submit

April 21, 2017

Conditions

Keywords

EMRESDResectionSTEREFTRSubmucosal dissectionEndoscopic resection

Outcome Measures

Primary Outcomes (1)

  • Number of participants with reduction in clinical symptoms

    To assess resolution of symptoms of all Endoscopic resection procedures at 6 months

    6 months from procedure

Secondary Outcomes (1)

  • Number of participants with treatment-related adverse events as assessed by CTCAE v4.0

    30 days post procedure

Other Outcomes (1)

  • Number of participants with successful completion of treatment

    30 days post procedure

Study Arms (1)

Endoscopic Resection

Patients undergoing Endoscopic Resection

Procedure: Endoscopic Resection

Interventions

Any Endoscopic resection for Gastrointestinal disorders including neoplasms.

Endoscopic Resection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Subjects undergoing Endoscopic resection procedures as part of their clinically indicated care

You may qualify if:

  • Any patient who is considering undergoing endoscopic resection within 6 months, or has undergone clinically indicated endoscopic resection within the past 6 months
  • Above or equal to 18 years of age.

You may not qualify if:

  • Any patient who has not undergone or will undergo endoscopic resection
  • Below 18 years of age.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weill Cornell Medical College

New York, New York, 10065, United States

RECRUITING

MeSH Terms

Conditions

Gastrointestinal NeoplasmsGastrointestinal DiseasesStomach NeoplasmsPolyposis, GastricEsophageal NeoplasmsDuodenal NeoplasmsNeoplasmsColonic PolypsColonic Neoplasms

Interventions

Endoscopic Mucosal Resection

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesStomach DiseasesHead and Neck NeoplasmsEsophageal DiseasesIntestinal NeoplasmsDuodenal DiseasesIntestinal DiseasesIntestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsColorectal NeoplasmsColonic Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Michel Kahaleh, MD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Michel Kahaleh, MD

CONTACT

Monica R Gaidhane, MPH

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief of Endoscopy

Study Record Dates

First Submitted

February 16, 2017

First Posted

February 27, 2017

Study Start

March 15, 2017

Primary Completion

March 1, 2020

Study Completion

April 1, 2020

Last Updated

April 25, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

No IPD Sharing

Locations